Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.
Press releases published on April 29, 2025
Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon
GlobeNewswire
·
April 29, 2025
Orchestra BioMed’s Virtue® Sirolimus AngioInfusion Balloon™ (“Virtue SAB”) is the only non-coated drug-eluting balloon system under clinical investigation worldwide and has been awarded multiple FDA Breakthrough Device Designations The Virtue Trial will be …
Ultralife Corporation to Report First Quarter Results on May 9, 2025
GlobeNewswire
·
April 29, 2025
NEWARK, N.Y., April 29, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2025 before the market opens on Friday, May 9, 2025. Ultralife’s Management will also host an …
MediaViz AI Launches AI Platform for Unmatched Media Curation and Analysis
GlobeNewswire
·
April 29, 2025
SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- MediaViz AI, a leader in human-centric AI for multimedia, today announced the launch of its most advanced platform yet. This new release combines cutting-edge automation with intuitive analysis to streamline …
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
GlobeNewswire
·
April 29, 2025
PALM BEACH, Fla., April 29, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to reports from industry insiders the Global AI in Diabetic Retinopathy market is projected to continue to grow at a substantial rate for years to come. …
Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk Women at AACR 2025
GlobeNewswire
·
April 29, 2025
SEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today outlined a framework for a pioneering …
Digital Utilities Ventures Announces Planned Name Change and Corporate Move as Strategic Evolution Continues
GlobeNewswire
·
April 29, 2025
Digital Utilities Ventures (OTC: DUTV) is evolving into Easy Environmental Solutions, Inc., to better reflect its focus on environmental sustainability. The company will continue to advance regenerative agriculture, clean water access, and a net carbon- …
Navigator Gas Announces Date for the Release of First Quarter 2025 Results and Zoom Conference Call
GlobeNewswire
·
April 29, 2025
LONDON, April 29, 2025 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, announces today that it will …
Moleculin Announces New Pre-Clinical Data for Annamycin Demonstrating Market Expansion Potential Including Treatment for Pancreatic Cancer
GlobeNewswire
·
April 29, 2025
Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 Annamycin is potentially a highly versatile drug capable of working synergistically with numerous mechanistically different FDA approved anticancer first line …
Helport AI Congratulates Brand Ambassador Ben Griffin on First PGA TOUR Victory at Zurich Classic
GlobeNewswire
·
April 29, 2025
Former Mortgage Loan Officer Turned PGA TOUR Champion Embodies Helport AI’s Mission to Empower Excellence SINGAPORE and SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Helport AI Limited (NASDAQ: HPAI) (“Helport AI” or the “Company”), an AI technology …
Progressive Announces Investor Relations Call
GlobeNewswire
·
April 29, 2025
MAYFIELD VILLAGE, OHIO, April 29, 2025 (GLOBE NEWSWIRE) -- As previously announced, The Progressive Corporation (NYSE: PGR) will host an Investor Relations conference call on Tuesday, May 6, 2025, beginning at 9:30 a.m. eastern time. This quarterly call, …
Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025
GlobeNewswire
·
April 29, 2025
SOUTH SAN FRANCISCO, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
SEON Powers Fraud Prevention for Tecovas Across the Brand’s Rapidly-Growing Retail and E-Commerce Operations
GlobeNewswire
·
April 29, 2025
AUSTIN, Texas, April 29, 2025 (GLOBE NEWSWIRE) -- SEON, a leader in digital fraud prevention and compliance, today announced Tecovas, the world’s fastest-growing Western brand, has adopted SEON's technology to strengthen security and streamline fraud …
Gaia Sets First Quarter 2025 Conference Call for Monday, May 12, 2025, at 4:30 p.m. ET
GlobeNewswire
·
April 29, 2025
BOULDER, Colo., April 29, 2025 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ: GAIA), a conscious media and community company, will conduct a conference call on Monday, May 12, 2025, at 4:30 p.m. Eastern time (2:30 p.m. Mountain time) to discuss its financial …
Locus Technologies Releases the First Fully Integrated Software Suite for Water Quality, Water Compliance, and Water Sustainability Programs
GlobeNewswire
·
April 29, 2025
MOUNTAIN VIEW, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Locus Technologies, the sustainability and Environmental Health and Safety (EHS) compliance software leader, announced the release of Locus Water, the first end-to-end, AI-ready software that has …
FYR Enters Know-How Agreement with Mayo Clinic to Collaborate on Blood-Based Biomarker Solutions for Parkinson’s Disease
GlobeNewswire
·
April 29, 2025
MISSOULA, Mont., April 29, 2025 (GLOBE NEWSWIRE) -- FYR, a biotechnology company leveraging extracellular vesicles (EVs) to dynamically observe disease and treatment responses, today announced a collaboration with Mayo Clinic seeking to advance the use of …
AP Biosciences Presents Preclinical Data on p95HER/CD137 T-Cell Engager at American Association of Cancer Research Annual Meeting
GlobeNewswire
·
April 29, 2025
TAIPEI, Taiwan, April 29, 2025 (GLOBE NEWSWIRE) -- AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced the presentation of new preclinical data for …
CytoDyn Leadership Team To Attend ESMO Breast Cancer Meeting in Munich, Germany
GlobeNewswire
·
April 29, 2025
Dr. Jacob Lalezari, CEO, and Dr. Richard Pestell, Lead Consultant in Preclinical and Clinical Oncology, to lead CytoDyn group in attendance VANCOUVER, Washington, April 29, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a …
Texas Space Commission Selects Intuitive Machines to Advance Earth Reentry and Microgravity Biomanufacturing Spacecraft
GlobeNewswire
·
April 29, 2025
HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- The Texas Space Commission has selected Intuitive Machines, Inc. (Nasdaq: LUNR) (“Intuitive Machines”) (“Company”), a leading space technology, infrastructure, and services company, for a grant up to $10 million …
Alico, Inc. to Announce Second Quarter 2025 Financial Results on Tuesday, May 13, 2025
GlobeNewswire
·
April 29, 2025
FORT MYERS, Fla., April 29, 2025 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that the Company will release financial results for the second quarter ended March 31, 2025, on Tuesday, May 13, 2025 after market …
Outbrain to Release First Quarter 2025 Financial Results on May 9, 2025
GlobeNewswire
·
April 29, 2025
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ: OB), which is operating under the new Teads brand, announced today that the company will release its first quarter 2025 results before the market opens on Friday, May 9, 2025, followed by …